Spire Healthcare Group (LON:SPI) had its target price decreased by Barclays from GBX 130 ($1.70) to GBX 115 ($1.50) in a report released on Friday morning, ThisIsMoney.Co.Uk reports. Barclays currently has an underweight rating on the stock.
SPI has been the topic of several other research reports. Credit Suisse Group downgraded Spire Healthcare Group to an underperform rating and decreased their price objective for the stock from GBX 170 ($2.22) to GBX 85 ($1.11) in a research note on Tuesday, February 12th. Peel Hunt reissued a hold rating on shares of Spire Healthcare Group in a research note on Tuesday, April 2nd. Liberum Capital reissued a hold rating on shares of Spire Healthcare Group in a research note on Thursday, March 14th. JPMorgan Chase & Co. reissued a neutral rating on shares of Spire Healthcare Group in a research note on Wednesday, January 2nd. Finally, Numis Securities reissued a buy rating and set a GBX 163 ($2.13) target price on shares of Spire Healthcare Group in a research note on Thursday, February 28th. Two equities research analysts have rated the stock with a sell rating, five have issued a hold rating and one has assigned a buy rating to the stock. The company currently has an average rating of Hold and a consensus target price of GBX 128.75 ($1.68).
LON SPI opened at GBX 141 ($1.84) on Friday. The company has a debt-to-equity ratio of 48.52, a quick ratio of 0.95 and a current ratio of 1.44. Spire Healthcare Group has a 52 week low of GBX 96.15 ($1.26) and a 52 week high of GBX 259.20 ($3.39). The stock has a market capitalization of $565.52 million and a PE ratio of 50.36.
The firm also recently announced a dividend, which will be paid on Tuesday, June 25th. Investors of record on Thursday, May 30th will be paid a dividend of GBX 2.50 ($0.03) per share. This represents a yield of 1.95%. The ex-dividend date is Thursday, May 30th. This is an increase from Spire Healthcare Group’s previous dividend of $1.30. Spire Healthcare Group’s dividend payout ratio (DPR) is 1.43%.
About Spire Healthcare Group
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. It provides a range of integrated surgical, medical, and diagnostic services. The company offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.
Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.